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Abstract
Background: Randomised controlled trials (RCTs) of complex interventions in primary health care (PHC) are needed
to provide evidence-based programmes to achieve the Declaration of Alma Ata goal of making PHC equitable,
accessible and universal and to effectively address the rising burden from chronic disease. Process evaluations of
these RCTs can provide insight into the causal mechanisms of complex interventions, the contextual factors, and
inform as to whether an intervention is ineffective due to implementation failure or failure of the intervention itself.
To build on this emerging body of work, we aim to consolidate the methodology and methods from process
evaluations of complex interventions in PHC and their findings of facilitators and barriers to intervention
implementation in this important area of health service delivery.
Methods: Systematic review of process evaluations of randomised controlled trials of complex interventions which
address prevalent major chronic diseases in PHC settings. Published process evaluations of RCTs will be identified
through database and clinical trial registry searches and contact with authors. Data from each study will be
extracted by two reviewers using standardised forms. Data extracted include descriptive items about (1) the RCT,
(2) about the process evaluations (such as methods, theories, risk of bias, analysis of process and outcome data,
strengths and limitations) and (3) any stated barriers and facilitators to conducting complex interventions. A
narrative synthesis of the findings will be presented.
Discussion: Process evaluation findings are valuable in determining whether a complex intervention should be
scaled up or modified for other contexts. Publishing this protocol serves to encourage transparency in the reporting
of our synthesis of current literature on how process evaluations have been conducted thus far and a deeper
understanding of potential challenges and solutions to aid in the implementation of effective interventions in PHC
beyond the research setting.
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Background
Why is this field of research important?
With a rapidly rising global burden of disease attributed
to non-communicable diseases, access to high quality
primary health care (PHC) is essential. Complex interven-
tions, defined as ‘interventions that comprise multiple
interacting components, although additional dimensions of
complexity include the difficulty of their implementation
and the number of organisational levels they target’, are
frequently deployed in an attempt to address health
system deficiencies experienced by patients and providers
[1]. Choosing a study design to assess effectiveness of
complex interventions is not straightforward, and it is rec-
ommended to consider randomisation to prevent selec-
tion bias and provide robust evidence [2, 3]. Process
evaluations, which are typically carried out in conjunction
with randomised controlled trials of such interventions,
can help explain for whom, how and why a complex inter-
vention had a particular impact [4].
Such evaluations address the question ‘Is this interven-
tion acceptable, effective, affordable and feasible (for me
or) for this population?’ [5]. Process evaluations can enable
patient-centred care by providing the opportunity for often
over-looked patients’ perspectives to be considered. As an
example, while a pragmatic trial of a cardiovascular polypill
in Australian PHC indicated the polypill was an effective,
cost-effective strategy for improving patient adherence and
the prescribing of indicated medications, our process
evaluation interviews found that clinicians need to consider
the polypill strategy alongside other evidence-based
strategies. These strategies should cater to specific pa-
tient factors such as health literacy, sense of well-being,
financial considerations, establishing ongoing respectful
clinician and patient relationships and improving acces-
sibility to health care [6].
Despite the generation of good quality evidence, this
often does not translate into improved health outcomes
[7]. A key barrier in the literature to research translation
is cost at different levels, e.g. high outpatient costs for
screening to the patient or cost of medications for the
programme [8–10]. While health economic evaluations
are increasingly being conducted as separate studies to
provide evidence of cost-effectiveness to decision makers,
there may be cost information that is relevant to the
objectives of a process which needs to be investigated. For
example, minimising indirect costs to patients is some-
thing that is important in understanding why an interven-
tion may be more acceptable to patients compared to
standard care. Conversely, for some, indirect costs associ-
ated with the intervention may discourage patients from
seeking care. These are economic issues which we propose
would be important to capture as part of process evalua-
tions but are not strictly captured in health economic
evaluations assessing the incremental cost-effectiveness of
interventions. It would be pertinent as part of a process
evaluation to incorporate relevant cost data from the on-
set, especially within PHC trials in low- and middle-
income countries (LMIC) and in populations which have
complex needs and limited funding to be allocated [9].
This would be important as part of a process evaluation,
to unpack whether for whom and how an intervention
can be implemented into routine practice after the trial is
completed. These findings from process evaluations can
then inform adoption of interventions into practice and
thus the scalability and sustainability of interventions [11].
What is known about this field currently?
Process evaluation methodology is evolving [4]. Process
evaluations were previously synonymous with qualitative
research alongside trials and were conducted to provide a
deeper understanding of the disease condition, implemen-
tation issues and mechanisms of the intervention [12].
However, there is a growing recognition that using quali-
tative and quantitative data (mixed methods) can help fa-
cilitate trial implementation and research translation
[13–15]. For instance, stratifying quantitative outcome
data by socio-economic status and triangulating it with
qualitative interviews, multi-level modelling and embed-
ded cost-analysis in a process evaluation may be useful in
determining the relevance and feasibility of a proven
effective complex intervention. Using mixed methods, a
clearer picture of the intervention may emerge that could
aid various stakeholders in their decision-making.
Although ‘one size fits all’ methods or methodologies
are not available, various theories or frameworks to
enhance implementation research have been used by
researchers to assist in their process evaluations. In early
2015, guidance was published by the Medical Research
Council (MRC) UK about the planning, conduct and
reporting of process evaluations to aid researchers, policy
makers and funders [11]. The article described the
proposed functions of process evaluations of looking
at feasibility and piloting, evaluation of effectiveness
and implementation post-evaluation during the different
stages of the development, evaluation and implementation
of a complex intervention. These functions expanded
upon the conventional definition of process evaluations
being limited to during trial implementation and defined
‘implementation’ as ‘the process through which interven-
tions are delivered, and what is delivered in practice’. For
example, during the post-evaluation implementation stage,
the authors recommend that the process evaluation serves
to explore how there is ‘routinisation of the intervention
into new contexts, and long term implementation/main-
tenance’. The authors suggest that this function of the
process evaluation is needed as reviews have showed
that post-trial, complex interventions are only partially
maintained. Key recommendations regarding the planning,
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design and conduct, analysis and reporting of process eval-
uations were also discussed in the MRC recommendations
[4, 11]. For example, arguments for whether there should
be a separation or integration of the process evaluation
and outcome evaluation teams were presented. The need
to integrate process and outcome data in the analysis and
the timing of when process data should be analysed in rela-
tion to outcome data were discussed.
The appraisal of the quality of process evaluations has
not been straightforward partly because of the variability
in methods [11, 16, 17]. Grant et al. in a literature review
found that the process evaluations were of poor and in-
consistent quality and proposed seven criteria for the
reporting of process evaluations including clearly label-
ling that it is a process evaluation [17]. Other sugges-
tions include appraising the quality of the process
evaluation based on the methods used. Given that most
process evaluations will have a qualitative component, a
set of criteria to examine the quality in the reporting of
qualitative research will be relevant to most process
evaluations [18, 19].
Dissemination and reporting of findings from process
evaluations especially in academic publications can also
be difficult due to a variety of reasons including feasibil-
ity due to limited resources for research projects, lag
time till dissemination of result or publication bias as
usually positive outcome trials will be reported but not
necessary negative trials [11, 20]. This in turn could limit
the likelihood of such relevant findings affecting policy
and practice.
Why do this review?
The George Institute for Global Health has a current
programme of research which focuses on addressing
NCDs through cost-effective and equitable strategies in
primary health care settings including LMIC, and with
indigenous populations [21]. Our studies trial complex
interventions such as capacity-building initiatives with
local providers [22], use of innovative mobile technology
[23], and cost-effective generic medications (e.g. polypill)
within primary health care settings [24]. We have found
that at times, despite acceptability and effectiveness of
these strategies, there are significant challenges that im-
pact upon their scale up. These barriers could be cul-
tural, political or institutional factors [25], but an
important reason for limited translation seems to lie in
the lack of understanding of implementation issues
within contextual factors for the different stakeholders
(e.g. patient, provider, policy makers). For example, while
a trial in India of a clinical decision support system on a
mobile tablet improved initial diagnosis and antihyper-
tensive management of trial patients, and was deemed
acceptable by end-users, only 35% of patients attended
the scheduled 1-month follow-up [23]. Interviews with
stakeholders found that limited patient accessibility to
medicines and doctors (for a variety of reasons including
inadequate staffing, limited primary health care infrastruc-
ture) as the key barrier which needs to be overcome. This
contrasts with other trials of electronic health tools (e.g.
decision support, text messages) in Australia which tend
towards generally more positive and sustained results as
such presumably because system issues were less of a sig-
nificant barrier given the universal and subsidised health
care available [26–28]. Given the greater burden of early
mortality from NCD in LMIC and disadvantaged popula-
tions [29], consolidating our findings in this proposed sys-
tematic review with an equity-focused lens to better
understand how to strengthen PHC within relevant con-
textual policy and system issues would be useful. Indeed,
systematic reviews of interventions in primary health care
have concluded that in addition to clinical outcomes, rigor-
ous evaluations of implementation outcomes (e.g. through
process evaluations) are needed to ensure changes in prac-
tice [30, 31]. We hope that this systematic review will add
to the process evaluation methodology and understanding
of effective implementation strategies in different PHC
settings [32, 33].
Objectives and key questions
To our knowledge, this is the first systematic review of
process evaluations of randomised controlled trial
(RCTs) in complex interventions in PHC. For complex
interventions, the pre-specification of a theory for how
an intervention is expected to work can be highly in-
formative in identifying the mechanisms by which an
intervention was hypothesised to have an impact and
why it was found to be successful (or not). It provides a
framework for assessing the behaviour of individual ac-
tors in the implementation of an intervention, potential
breakdowns in the interactions between parties and puts
into context these actions. Thus, findings from process
evaluations from both positive and negative trials can shed
light upon implementation facilitators and barriers, which
would add to the collective lessons for researchers. More-
over, given that there are numerous theories and frame-
works in this area, we thought it would be informative to
describe the breadth of methods used and to make some
recommendations on evaluation methods that should be
incorporated into PEs of complex interventions. Thus,
we aim to consolidate the methodology and methods
from process evaluations of complex interventions in
PHC and their findings of facilitators and barriers to
intervention implementation in this important area of
health service delivery.
These objectives will be achieved through addressing
these questions: (a) Is there and what is the explicit theory
behind the conducted process evaluations? (e.g. normal-
isation process theory, realist framework); (b) What are
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the methods used in these process evaluations? (e.g. quali-
tative research through semi-structured interviews, sur-
veys); (c) At what stage is the process evaluation done?
(i.e. feasibility and piloting, evaluation of effectiveness, or
post-evaluation implementation.); (d) If an aim is stated
(i.e. in the evaluation of effectiveness stage), how are the
results of the RCT integrated with the findings from the
process evaluations?; (e) What are the strengths, limita-
tions and potential solutions identified by the authors in
conducting the process evaluations?; and (f) What are the
barriers and facilitators to the implementation of complex
interventions identified by the authors?
Methods/design
This systematic review will focus on process evaluations
of RCTs of complex interventions addressing chronic
disease in PHC. We have described our methods as per
Preferred Reporting Items for Systematic Review and
Meta-Analysis for protocol (PRISMA-P) recommendations,
and this checklist is included as an Additional file 1 [34].
Eligibility criteria
Definitions as per PICO-D have been adapted for the
purpose of this review [20, 35]:
Participants—participants include patients and health
providers in the PHC setting addressing the prevalent
chronic diseases as defined by the World Health Organi-
sation—cardiovascular disease, chronic kidney disease,
chronic respiratory disease, type 2 diabetes mellitus and
depression. PHC as defined by the Alma-Ata declaration
[36] as health services provided within the community
setting by doctors, nurses and allied health with the goal to
achieve better health for all through reforms in universal
coverage, public policy, service delivery and leadership [37].
‘Intervention’—complex interventions defined as those
‘interventions that comprise multiple interacting compo-
nents, although additional dimensions of complexity in-
clude the difficulty of their implementation and the
number of organisational levels they target’ within PHC
[4]. This includes a single-faceted intervention that re-
quires multiple actors or pathways and thus makes the
implementation complex. It is envisaged that the com-
plex interventions for chronic diseases (if not explicitly
defined as a complex intervention) will have elements of
the Wagner chronic care model such as community sup-
port, case management, self-management, facilitated
family support, organisational change, delivery system
design, decision support for health care providers and
clinical information systems [38].
Comparator—not applicable
‘Outcomes’—(1) findings from the process evaluations
of stated implementation barriers and facilitators to the
complex intervention. (2) The stated strengths and limi-
tations of the process evaluation methodology from the
perspectives of the authors. Both findings will be useful
for future conduct of complex interventions in PHC in
the planning, conduct of process evaluations and in the
consideration of intervention implementation and what
barriers need to be overcome in different PHC settings.
Timing—years of search from 1998. This was chosen
because a systematic review by Davies et al. shows that
there was poor use of theory in implementation research
until at least 1998 [39].
Design—process evaluations of randomised controlled
trials of complex interventions in PHC. Process evaluation
as defined by ‘a study which aims to understand the func-
tioning of an intervention, by examining implementation,
mechanisms of impact, and contextual factors’ [11]. As
discussed by Grant et al., because process evaluations are
not clearly labelled as such, qualitative research conducted
alongside RCTs with similar aims will be included [17, 40].
Exclusion criteria—articles were excluded if they were
not a journal article, not a report based on empirical
research (e.g. protocol, editorial), not reported in English
and reviews and not human research.
Search strategy
Information sources
Databases reporting academic publications (MEDLINE,
SCOPUS, PsychInfo, CINAHL, EMBASE, Global Health.)
In order to locate any process evaluations whose findings
were not published or missed in the database searches, we
will search major clinical trial registries for completed
process evaluations (e.g. Cochrane Central Registry of
Controlled Trials, EU registry, ANZTRN and clinical trial
registry (USA)). Authors will be contacted in regard to the
outcomes of the RCT and findings of their completed
process evaluations.
A search strategy was developed and adapted for each
database with the initial support of a medical research
librarian. Search terms were based on the review objec-
tives and early scoping searches (see Additional file 2:
search strategy), key words: process evaluations (including
programme evaluation, qualitative research), complex
intervention (including chronic care model and its com-
ponents of community support, case management, self-
management, facilitated family support, organisational
change, delivery system design, decision support for health
care providers and clinical information systems), rando-
mised controlled trials, PHC (including family practice,
general practitioners) and chronic disease (including car-
diovascular disease, chronic kidney disease, chronic re-
spiratory disease, type 2 diabetes mellitus and depression).
Study records
Data management
After the searches, the shortlisted articles will be exported
to Endnote. Data will be stored in a common file that is
Liu et al. Systematic Reviews  (2016) 5:138 Page 4 of 7
password protected on the Institute’s server that is access-
ible by the two reviewers. At each stage of the data selec-
tion process during the review (e.g. after consolidation of
all articles prior to assessing eligibility based on title and
abstract), back up files of the endnote database will be
made in order to retrace any steps as needed in the review
process, and for any third party adjudication.
Selection process
Two reviewers will screen all titles and abstracts identify-
ing potential eligible studies based on inclusion and exclu-
sion criteria, and duplicates are to be removed. This will
be done independently to reduce the risk of bias. All
eligible studies will be retrieved in full text and reviewed
by the two reviewers using predesigned eligibility forms
(see Additional file 3). Disagreements will be resolved by
consensus of a third party in the review team.
Data collection process
Data from all included studies will be extracted by two
reviewers using the eligibility and data extraction forms.
The data extraction forms (see Additional file 4) were
partly guided by the MRC recommendation for process
evaluations and Grant et al.’s suggested minimal factors
for reporting on process evaluations [4, 17]. The forms
will be pilot tested by the two reviewers on the same
three articles, iterative changes will be made when
appropriate and the two reviewers will independently ex-
tract data from the rest of the included list of articles.
Data items
Variables to be extracted include data on the RCT and its
process evaluation: (1) RCT—study design, setting (rural,
urban, country), results (positive, negative or equivalent);
(2) process evaluation—any published process evaluation
protocol or evidence of pre-specified process evaluation in
the main trial protocol, or stated aims of the process
evaluation (e.g. examining recruitment, or explaining
results), the process evaluation theory, justified methods
of integrating trial and process outcomes, stage during
which the process evaluation is done (feasibility and
piloting, evaluation of effectiveness and post-evaluation
implementation), methods of analysis and inclusion of
costs incurred.
Outcomes and prioritisation
The outcomes of interest for our aims are (1) the stated
strengths and limitations of the process evaluation meth-
odology from the perspectives of the authors and (2)
findings from the process evaluation of stated imple-
mentation barriers and facilitators of the complex inter-
vention. Both findings will be useful for future conduct
of complex interventions in PHC—in the planning, con-
duct of process evaluations and when considering the
scaling up of an interventions and what barriers need to
be overcome in a PHC setting depending on context [1].
For example, the community’s need, the type of model
or availability of PHC services will be different in
developed settings as compared to LMIC.
Risk of bias in individual studies
For this review, we drew on the use of Tong et al.’s cri-
teria for reporting of qualitative studies [19], on Grant
et al.’s proposed framework of minimal requirements for
the reporting of process evaluations of cluster rando-
mised controlled trials [17] and on MRC recommenda-
tions for process evaluations of complex interventions
[4]. Combining insights from these papers, a form of ap-
praisal for risk of bias was derived (see Additional file 5).
For the purposes of this review in examining the use of
process evaluations alongside RCTs in PHC, studies
were not excluded based on quality [20]. Instead, the
quality of the studies is presented as a risk of bias graph
(low, unclear and high risk) [41].
Data synthesis
This will involve the aggregation or synthesis of qualitative
findings to generate a set of statements that represent that
aggregation and categorisation of these findings on the
basis of similarity in meaning and contexts. These categor-
ies will then be subjected to thematic synthesis in order to
produce a single comprehensive set of synthesised find-
ings that can be used as a basis for evidence-based prac-
tice. The synthesis of these qualitative data aims to satisfy
the criteria established for the reporting of the synthesis of
qualitative health research [18]. Abstracted quantitative
data (e.g. number of positive trials) will be presented to-
gether with a descriptive narrative form including tables
and figures to aid in data presentation where appropriate.
We will examine how authors address potential bias
through a narrative synthesis how well these are reported
in the papers and strategies that may have been employed
to mitigate this (e.g. triangulation of key findings). De-
pending on papers included, there may be subgroup ana-
lysis of further exploration of any differences of the
barriers and facilitators to intervention implementation by
context such as indigenous versus non-indigenous and of
developed settings as compared to LMIC.
Discussion
There is a global call for PHC reform in the areas of
service delivery, public policy and leadership to enable
greater equity and improved health to different popula-
tions. To effect this change will require complex interven-
tions involving multiple players (clinicians, community,
allied health professionals, policy makers), disciplines
(e.g. education, health) and what is successful in one con-
text may not be suitable in another. Process evaluations
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conducted alongside RCTs of complex health interven-
tions are valuable in determining whether a complex
intervention should be scaled up or modified for other
contexts.
The conduct of process evaluations is still a dynamic
area with no clear defined method, partly due to the
spectrum of methods (e.g. observation, interviews and
routine monitoring data). De Silva et al. in 2014 outlined
the integration of the Theory of Change into the MRC
framework for complex interventions, and one of its
aims was to combine ‘process and effectiveness indicators
into a single analysis which can help untangle whether,
how and why an intervention has an impact in a par-
ticular context, and whether it may be suitable for scale
up or adaptation for new settings’ [42]. Moreover, in re-
gard to future scale up of complex interventions, eco-
nomic issues pertinent to stakeholders (e.g. patients and
providers) would be crucial to policy makers and fun-
ders—while this has not been traditionally incorporated
together with process evaluations, it would be helpful to
see if it has been done [35, 43].
Process evaluations of complex interventions have
been increasing in recent years and seem to be variable
in objectives, methodology and quality. The MRC guidance
in the conduct of process evaluations and in the interpret-
ation of the RCT outcomes may be helpful for researchers
to aid in the implementation of effective interventions be-
yond the research setting. This protocol outlines our
methods and design in our efforts to systematically con-
solidate the collective experience of researchers in this field
in conducting, analysing and reporting process evaluations
by assembling the findings within the MRC’s process
evaluation recommendations and to understand previous
challenges and potential solutions in the implementation
of evidence-based complex interventions in PHC accord-
ing to context.
Additional files
Additional file 1: PRISMA-P checklist. (DOC 82 kb)
Additional file 2: Example of search strategy. (PDF 314 kb)
Additional file 3: Eligibility forms. (DOCX 14 kb)
Additional file 4: Data extraction form comprising of four tables.
(DOC 34 kb)
Additional file 5: Form of appraisal for risk of bias. (DOC 33 kb)
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